Stage-Based Management of Type 2 Diabetes Mellitus with Heart Failure

Methodist DeBakey Cardiovascular Journal
Patricia Mejia OsunaDale J Hamilton

Abstract

Type 2 diabetes negatively impacts heart failure outcomes. Insulin resistance, central adiposity, dyslipidemia, and altered cellular substrate metabolism each have a mechanistic role. Management strategies focused solely on glycemic control have had limited success. However, three new classes of drugs, each with several options, offer the promise of improved diabetes management in heart failure. Unlike earlier classes, these medications have had favorable cardiovascular outcomes. In this review, we present a therapeutic guide for metabolic treatment based on the stages of heart failure.

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Related Papers

Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
John W Newcomer, Dan W Haupt
Current Diabetes Reports
C DesouzaV Fonseca
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Raju A GopalNalini S Shah
© 2022 Meta ULC. All rights reserved